Healthcare -
Biotechnology - NASDAQ - US
$ 24.2
-13.6 %
$ 17.9 B
Market Cap
-71.18
P/E
SMMT - REVENUE
Revenue SMMT - Summit Therapeutics Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR